Cervix BT - 2016

Conclusion (I)

 Dose effect demonstrated for:

 Residual GTV D100, adaptive CTV HR

D90, and CTV IR

D90

 Bladder D 2cm 3  Rectum D 2cm 3  Vagina (recto-vaginal point)

 Dose effect not demonstrated for  Sigmoid and bowel  Dose to adhesive bowel loops may be important!  Perspective: prospective dose prescription protocol taking into account multiple parameters:  Target dose, volume and overall treatment time 

31